FDA.reportPublic FDA data

Application 070102

Type
ANDA
Sponsor
TEVA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DISOPYRAMIDE PHOSPHATEDISOPYRAMIDE PHOSPHATECAPSULE;ORALEQ 150MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-3129Disopyramide PhosphateDisopyramide PhosphateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3129Disopyramide PhosphateDisopyramide PhosphateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3129Disopyramide PhosphateDisopyramide PhosphateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3129Disopyramide PhosphateDisopyramide PhosphateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3129Disopyramide PhosphateDisopyramide PhosphateTeva Pharmaceuticals USA, Inc.ANDACurrent
42291-235Disopyramide PhosphateDisopyramide PhosphateAvKARE, Inc.ANDACurrent
42291-235Disopyramide PhosphateDisopyramide PhosphateAvKAREANDACurrent
68151-0528Disopyramide PhosphateDisopyramide PhosphateCarilion Materials ManagementANDACurrent